13D/13G Filings - Versant Venture Capital VI L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-11-09
5:24 pm
Unchanged
2023-08-1113DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.4,328,883
8.400%
0
(Unchanged)
Filing
History
2023-02-09
4:19 pm
Sale
2022-12-3113GCentury Therapeutics, Inc.
IPSC
Versant Venture Capital VI L.P.11,452,014
19.400%
-914,800decrease
(-7.40%)
Filing
History
2023-01-13
4:09 pm
Sale
2023-01-0313DOyster Point Pharma, Inc.
OYST
Versant Venture Capital VI L.P.0
0.000%
-2,236,888decrease
(Position Closed)
Filing
History
2022-05-09
5:26 pm
Purchase
2022-04-2913DTempest Therapeutics, Inc.
TPST
Versant Venture Capital VI L.P.162,973
20.500%
72,321increase
(+79.78%)
Filing
History
2022-02-10
8:39 pm
Purchase
2021-12-3113GCentury Therapeutics, Inc.
IPSC
Versant Venture Capital VI L.P.12,366,814
22.600%
12,366,814increase
(New Position)
Filing
History
2022-02-10
7:41 pm
Purchase
2021-12-3113GTempest Therapeutics, Inc.
TPST
Versant Venture Capital VI L.P.90,652
17.100%
90,652increase
(New Position)
Filing
History
2022-01-13
4:34 pm
Unchanged
2022-01-0513DOyster Point Pharma, Inc.
OYST
Versant Venture Capital VI L.P.2,236,888
8.500%
0
(Unchanged)
Filing
History
2021-10-27
4:32 pm
Unchanged
2021-10-1813DOyster Point Pharma, Inc.
OYST
Versant Venture Capital VI L.P.2,236,888
8.600%
0
(Unchanged)
Filing
History
2021-07-09
4:43 pm
Purchase
2021-06-2913DGraphite Bio, Inc.
GRPH
Versant Venture Capital VI L.P.2,101,200
26.300%
2,101,200increase
(New Position)
Filing
History
2021-07-08
4:31 pm
Purchase
2021-06-2813DMonte Rosa Therapeutics, Inc.
GLUE
Versant Venture Capital VI L.P.6,799,115
15.300%
6,799,115increase
(New Position)
Filing
History
2021-06-21
4:44 pm
Sale
2021-06-1113DAligos Therapeutics, Inc.
ALGS
Versant Venture Capital VI L.P.58,317
3.800%
-19,439decrease
(-25.00%)
Filing
History
2021-05-24
4:27 pm
Unchanged
2021-05-1213DOyster Point Pharma, Inc.
OYST
Versant Venture Capital VI L.P.2,236,888
8.600%
0
(Unchanged)
Filing
History
2021-05-03
4:57 pm
Sale
2021-04-2613DAligos Therapeutics, Inc.
ALGS
Versant Venture Capital VI L.P.77,757
5.100%
-19,439decrease
(-20.00%)
Filing
History
2021-04-08
4:31 pm
Purchase
2021-03-2913DLAVA Therapeutics N.V.
LVTX
Versant Venture Capital VI L.P.3,407,157
13.400%
3,407,157increase
(New Position)
Filing
History
2021-04-05
4:33 pm
Unchanged
2021-03-2613DOyster Point Pharma, Inc.
OYST
Versant Venture Capital VI L.P.2,236,888
8.600%
0
(Unchanged)
Filing
History
2021-03-01
5:16 pm
Sale
2021-02-1713DOyster Point Pharma, Inc.
OYST
Versant Venture Capital VI L.P.2,236,888
8.600%
-325,000decrease
(-12.69%)
Filing
History
2021-02-12
8:41 pm
Sale
2020-12-3113GAkero Therapeutics, Inc.
AKRO
Versant Venture Capital VI L.P.777,727
2.200%
-2,878,858decrease
(-78.73%)
Filing
History
2020-12-03
4:47 pm
Sale
2020-11-2313DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.4,328,883
12.000%
-1,031,634decrease
(-19.25%)
Filing
History
2020-11-20
5:32 pm
Sale
2020-11-1113DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.5,360,517
14.900%
-980,734decrease
(-15.47%)
Filing
History
2020-10-30
4:25 pm
Purchase
2020-10-2013DAligos Therapeutics, Inc.
ALGS
Versant Venture Capital VI L.P.97,196
7.200%
97,196increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, Next